Expanding Treatment Options for Patients with Severe Aortic Stenosis: The Lotus and ACURATE neo Valves

 

AGENDA:

 

REPRISE III and Beyond: Technology Overview and the Latest Clinical Data for the Lotus Valve


Dean J. Kereiakes, MD, The Christ Hospital, Cincinnati, OH

 


ACURATE neo TF Valve: Review of the Device and the SAVI TF1000 Data


Helge Möllmann, MD, St. Johannes Hospital Dortmund, Dortmund, Germany


Two Valves, One Practice: Case Examples With the Lotus and the ACURATE neo Valves

480});


Thomas Pilgrim, MD, Bern University Hospital, Bern, Switzerland


Lotus and ACURATE neo TF in Perspective

 


Ted Feldman, MD, NorthShore University HealthSystem, Evanston, IL

Expanding Treatment Options for Patients with Severe Aortic Stenosis: The Lotus and ACURATE neo Valves

 

 

This program was supported by Boston Scientific:    Expanding Treatment Options for Patients with Severe Aortic Stenosis: The Lotus and ACURATE neo Valves